WO2006120696A3 - An improved pharmaceutical composition - Google Patents

An improved pharmaceutical composition Download PDF

Info

Publication number
WO2006120696A3
WO2006120696A3 PCT/IN2006/000054 IN2006000054W WO2006120696A3 WO 2006120696 A3 WO2006120696 A3 WO 2006120696A3 IN 2006000054 W IN2006000054 W IN 2006000054W WO 2006120696 A3 WO2006120696 A3 WO 2006120696A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
present
improved pharmaceutical
etiology
injury
Prior art date
Application number
PCT/IN2006/000054
Other languages
French (fr)
Other versions
WO2006120696A2 (en
Inventor
Rajeev Raut
Original Assignee
Rajeev Raut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rajeev Raut filed Critical Rajeev Raut
Priority to JP2007555780A priority Critical patent/JP4239036B2/en
Publication of WO2006120696A2 publication Critical patent/WO2006120696A2/en
Publication of WO2006120696A3 publication Critical patent/WO2006120696A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

The present invention relates to a pharmaceutical composition containing 4-aminoquinoline compounds and Magnesium chloride for treatment of ocular inflammation of varied etiology such as immune disease factors, surgery, chemical or mechanical injury or prevention of injury due to exposure to radiation, infra-red or ultra-violet rays, degenerative changes, allergic or infective etiology using the novel pharmaceutical composition of the present invention.
PCT/IN2006/000054 2005-02-21 2006-02-20 An improved pharmaceutical composition WO2006120696A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007555780A JP4239036B2 (en) 2005-02-21 2006-02-20 Improved pharmaceutical composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN182MU2005 2005-02-21
IN182/MUM/2005 2005-02-21

Publications (2)

Publication Number Publication Date
WO2006120696A2 WO2006120696A2 (en) 2006-11-16
WO2006120696A3 true WO2006120696A3 (en) 2007-01-04

Family

ID=37059683

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2006/000054 WO2006120696A2 (en) 2005-02-21 2006-02-20 An improved pharmaceutical composition

Country Status (2)

Country Link
JP (1) JP4239036B2 (en)
WO (1) WO2006120696A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2057983A1 (en) * 2007-11-07 2009-05-13 Bruschettini S.r.l. Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations
WO2009089399A2 (en) * 2008-01-10 2009-07-16 Bausch & Lomb Incorporated Compositions comprising toll-like receptor or coreceptor antagonists and methods for ocular neuroprotection
WO2009089401A2 (en) * 2008-01-10 2009-07-16 Bausch & Lomb Incorporated Compositions comprising toll-like receptor or coreceptor antagonists and methods for treating or controlling ocular allergy using same
KR101067443B1 (en) * 2009-06-23 2011-09-27 여오영 Local injection composition comprising hydroxychloroquine for treatment of hemorrhoids

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097025A2 (en) * 2002-05-17 2003-11-27 Rajeev Raut A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097025A2 (en) * 2002-05-17 2003-11-27 Rajeev Raut A process for preparing pharmaceutical compositions containing 4-aminoquinolines compounds for treatment of inflammatory disorders of the eye and compositions resulting therefrom

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EGBE-NWIYI T N ET AL: "The effect of high oral magnesium chloride supplementation on the pathogenicity of Trypanosoma brucei brucei and T. congolense infections in rats.", TROPICAL VETERINARIAN, vol. 21, no. 3, 2003, pages 152 - 159, XP001247134, ISSN: 0794-4845 *

Also Published As

Publication number Publication date
JP2008530202A (en) 2008-08-07
JP4239036B2 (en) 2009-03-18
WO2006120696A2 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
WO2007068894A3 (en) Substituted diphenylethers, -amines, -sulfides and -methanes for the treatment of respiratory disease
WO2007064883A3 (en) Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
NO20062767L (en) immunoglobulins
NO20055894L (en) Methods and compositions for the treatment of amyloid-related diseases
EA200701746A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF DISEASES, INCLUDED IN THE SERIAL, OBJECTIVE, DIABETES, METABOLIC SYNDROME, NEURODEGENERATIVE DISEASES AND DISEASES, CONNECTED, CONNECTED, DISRUPTED, DISORDERS
WO2005094785A3 (en) Compositions capable of facilitating penetration across a biological barrier
WO2007011941A3 (en) Human anti-b7rp1 neutralizing antibodies
WO2007064932A3 (en) Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2006107947A3 (en) Hyperspectral imaging in diabetes and peripheral vascular disease
WO2006104826A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2006058869A3 (en) Substituted pteridines for treating inflammatory diseases
EA200801481A1 (en) 5- (AROSULFONYL) PYRAZOLOPIPERIDES
ATE523495T1 (en) SUBSTITUTED PYRAZOLINE COMPOUNDS, THEIR PREPARATION AND USE AS MEDICATIONS
ATE508114T1 (en) ISOINDOLYL COMPOUNDS SUBSTITUTED WITH N-ALKYLHYDROXAMIC ACIDS AND THEIR PHARMACEUTICAL USE
WO2007123939A8 (en) Novel arylamino n-heteraryls as mek inhibitors
EA200801343A1 (en) IMMUNOGLOBULINS DIRECTED AGAINST NOGO
TW200628473A (en) Novel heterocycles
WO2006056607A8 (en) Substituted pteridines for treating inflammatory diseases
WO2007056366A3 (en) Compounds and compositions as ppar modulators
WO2007038425A3 (en) Anti-viral compouinds
WO2010067078A3 (en) 3,6-disubstituted xanthylium salts as medicaments
CL2007003189A1 (en) COMPOUNDS DERIVED FROM INDOL AND BENZOFURAN; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OR PREVENTION OF ALZHEIMER'S DISEASE.
WO2007058805A3 (en) Compositions and methods for treating cns disorders
WO2006120696A3 (en) An improved pharmaceutical composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007555780

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06766246

Country of ref document: EP

Kind code of ref document: A2

WWW Wipo information: withdrawn in national office

Ref document number: 6766246

Country of ref document: EP